ISPOR Europe 2022
This year the ISPOR Europe will take place with SKC's collegae in attendance in Vienna from the 6th until the 9th of November.
Vienna, AU,
06 - 09.11.2022
Following this year's maxim "Collaborating Across Borders: Building & Using Evidence to Enable Access" we are pleased to be attending this significant conference to gain inspiring and innovative insights for SKC's future activities. SKC is looking forward to interact with the global HEOR community.
In addition, we actively contribute to the conference with our latest research results. Meet the SKC team at poster presentations on the following topics:
November 7th, 10:00 a.m. - 1:15 p.m.
- Outcomes of Benefit Assessments of Orphan Drugs Without Orphan Designation in Germany
- Last Resort for Reimbursement of New Drugs in Germany: When the Arbitration Office Must Decide
November 8th, 10:00 a.m. - 1:15 p.m.
- From Vague to Valid – Chances and Risks of Benefit Re-Assessments Due to New Scientific Evidence in Germany
- Is No Therapy a Therapy? Effects of Watchful Waiting as Appropriate Comparator Therapy for New Drugs on Benefit Assessment and Pricing in Germany
November 8th, 3:00 p.m. - 6:15 p.m.
Join us in Vienna at ISPOR Europe 2022 to discuss the next decade of transformation in healthcare decision making. We look forward to seeing you.
Get in touch
Dipl.-Kauffrau Heike Kielhorn-Schönermark
Founder and Managing Director
Founder and Managing Director
Fon: +49 511 64 68 14 – 0
Fax: +49 511 64 68 14 18
Fax: +49 511 64 68 14 18
